SMAD4 and cancer: Testing the association between these signaling nodes and previously assessed surrogate markers of cancer risk using Pearson's correlation analysis revealed a significant positive correlation between ALDH+ and centrosome aberrations (P<0.05) and pATF2 and SMAD4 (P<0.05) (Sup.